Skip to main content

India Hook-Barnard, PhD, Appointed as Director of Research Strategy

Printer-friendly versionPrinter-friendly version

Published: 02/12/2015

hook barnard
Photo: Sarah Paris
 

India Hook-Barnard, PhD, has been appointed Director of Research Strategy in the School of Medicine Dean’s Office, the position formerly held by Terri O’Brien.

She will work with Executive Vice Dean Keith Yamamoto in developing and supporting research and research training programs, directing efforts to secure major research and infrastructure funding, and providing advice, consultation and analysis on scientific initiatives. She will also work with Yamamoto in his role as vice chancellor for research, supporting basic, clinical and social and behavioral research development and the pursuit of precision medicine, the over-arching conceptual and organizational platform for research on our campus.

Her background in research strategy includes a wide spectrum of scientific discovery, translational research and clinical medicine, as well as policy, regulation, ethical and societal concerns. Since 2008, she has worked with the National Academies, first as a senior program officer with the National Academy of Sciences (NAS) Board on Life Sciences and most recently as a senior program officer at the Institute of Medicine’s (IOM) Board on Health Sciences Policy. At the NAS and IOM, she developed and administered programs, working with boards and committees comprised of distinguished academic faculty, scientists, engineers, clinicians, business leaders and policy experts.

Hook-Barnard served as the study director for six National Academies reports, including the pivotal Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease, co-chaired by then UCSF chancellor Sue Desmond-Hellmann, with Drs. Keith Yamamoto and Bernard Lo among its committee members. Most recently, she directed the just released IOM report Sharing Clinical Trial Data, chaired by Dr. Bernard Lo, with Dr. Ida Sim among the committee members.

She earned a PhD in microbiology (medicine) at University of Missouri and was a postdoctoral fellow at the NIH.